Article Text

Download PDFPDF

Anticipatory syringe drivers: a step too far
  1. Ben Bowers1,
  2. Richella Ryan1,
  3. Sarah Hoare1,
  4. Kristian Pollock2 and
  5. Stephen Barclay1
  1. 1 Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom
  2. 2 School of Health Sciences, University of Nottingham, Nottingham, United Kingdom
  1. Correspondence to Mr Ben Bowers, Department of Public Health and Primary Care, University of Cambridge, Cambridge CB1 8RN, UK; bb527{at}medschl.cam.ac.uk

Statistics from Altmetric.com

The recent Gosport War Memorial Hospital inquiry1 has increased UK patient, public and clinician awareness about syringe drivers for continuous subcutaneous delivery of opioids and other medications at the end of life.2 3 The inquiry found that at least 456 patients died where opioids had been prescribed and administered in unjustified doses, commonly via syringe drivers. In safe hands, syringe drivers facilitate appropriate and effective control of pain and other symptoms for patients who are no longer able to swallow or absorb oral medication, commonly when close to the end of life. The Gosport findings highlight the importance of ‘safe hands’. In an overstretched clinical climate in which clinicians are encouraged to plan ahead to optimise patient care, Gosport is a timely warning of the potential dangers of ‘anticipatory syringe drivers’ prescribed in anticipation of future symptoms at the end of life.

The anticipatory prescribing and administration of opioids in Gosport hospital was highly anomalous and did not reflect standard palliative care practice. A serious category error was common; most people were in hospital for rehabilitation and were …

View Full Text

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.